Outcomes Similar In ‘Mini Transplant’ Patients’ When Using Related And Unrelated Donor Cells

People who undergo nonmyeloablative stem-cell transplants, or “mini transplants,” for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.The research by Marco Mielcarek, M.D. [click link for full article]

More: continued here

Filed under: Lymphoma / Leukemia on December 6th, 2007